Lowe SW - Search Results

1

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.

Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. Xue W, et al. Among authors: lowe sw. Genes Dev. 2008 Jun 1;22(11):1439-44. doi: 10.1101/gad.1672608. Genes Dev. 2008. PMID: 18519636 Free PMC article.

2

Oncogene-dependent apoptosis in extracts from drug-resistant cells.

Fearnhead HO, McCurrach ME, O'Neill J, Zhang K, Lowe SW, Lazebnik YA. Fearnhead HO, et al. Among authors: lowe sw. Genes Dev. 1997 May 15;11(10):1266-76. doi: 10.1101/gad.11.10.1266. Genes Dev. 1997. PMID: 9171371 Free article.

3

E1A signaling to p53 involves the p19(ARF) tumor suppressor.

de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. de Stanchina E, et al. Among authors: lowe sw. Genes Dev. 1998 Aug 1;12(15):2434-42. doi: 10.1101/gad.12.15.2434. Genes Dev. 1998. PMID: 9694807 Free PMC article.

4

Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.

Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Lin AW, et al. Among authors: lowe sw. Genes Dev. 1998 Oct 1;12(19):3008-19. doi: 10.1101/gad.12.19.3008. Genes Dev. 1998. PMID: 9765203 Free PMC article.

5

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

Soengas MS, Alarcón RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW. Soengas MS, et al. Among authors: lowe sw. Science. 1999 Apr 2;284(5411):156-9. doi: 10.1126/science.284.5411.156. Science. 1999. PMID: 10102818

6

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. Schmitt CA, et al. Among authors: lowe sw. Genes Dev. 1999 Oct 15;13(20):2670-7. doi: 10.1101/gad.13.20.2670. Genes Dev. 1999. PMID: 10541553 Free PMC article.

7

PML is induced by oncogenic ras and promotes premature senescence.

Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. Ferbeyre G, et al. Among authors: lowe sw. Genes Dev. 2000 Aug 15;14(16):2015-27. Genes Dev. 2000. PMID: 10950866 Free PMC article.

8

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, Lowe SW. Soengas MS, et al. Among authors: lowe sw. Nature. 2001 Jan 11;409(6817):207-11. doi: 10.1038/35051606. Nature. 2001. PMID: 11196646

9

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.

Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW, Powers S. Li J, et al. Among authors: lowe sw. Nat Genet. 2002 Jun;31(2):133-4. doi: 10.1038/ng888. Epub 2002 May 20. Nat Genet. 2002. PMID: 12021784

10

Dissecting p53 tumor suppressor functions in vivo.

Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. Schmitt CA, et al. Among authors: lowe sw. Cancer Cell. 2002 Apr;1(3):289-98. doi: 10.1016/s1535-6108(02)00047-8. Cancer Cell. 2002. PMID: 12086865 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page